These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23871664)

  • 1. Effects of genetic variation on the E. coli host-circuit interface.
    Cardinale S; Joachimiak MP; Arkin AP
    Cell Rep; 2013 Jul; 4(2):231-7. PubMed ID: 23871664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-based synthetic genetic screens to map bacterial pathways and functional networks in Escherichia coli.
    Babu M; Gagarinova A; Greenblatt J; Emili A
    Methods Mol Biol; 2011; 765():125-53. PubMed ID: 21815091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array-based synthetic genetic screens to map bacterial pathways and functional networks in Escherichia coli.
    Babu M; Gagarinova A; Emili A
    Methods Mol Biol; 2011; 781():99-126. PubMed ID: 21877280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of evolutionary stability dynamics and competitive fitness of Escherichia coli engineered with randomized multigene circuits.
    Sleight SC; Sauro HM
    ACS Synth Biol; 2013 Sep; 2(9):519-28. PubMed ID: 24004180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression of a heterologous gene in Escherichia coli in response to carbon-nitrogen source and C/N ratio in a batch bioreactor.
    Bhattacharya SK; Dubey AK
    Biotechnol Prog; 1997; 13(2):151-5. PubMed ID: 9104039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory trade-off as a source of strain variation in the species Escherichia coli.
    King T; Ishihama A; Kori A; Ferenci T
    J Bacteriol; 2004 Sep; 186(17):5614-20. PubMed ID: 15317765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthogonality and Burdens of Heterologous AND Gate Gene Circuits in E. coli.
    Liu Q; Schumacher J; Wan X; Lou C; Wang B
    ACS Synth Biol; 2018 Feb; 7(2):553-564. PubMed ID: 29240998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous production of ribostamycin derivatives in engineered Escherichia coli.
    Kurumbang NP; Park JW; Yoon YJ; Liou K; Sohng JK
    Res Microbiol; 2010 Sep; 161(7):526-33. PubMed ID: 20561584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Escherichia coli for efficient cellobiose utilization.
    Vinuselvi P; Lee SK
    Appl Microbiol Biotechnol; 2011 Oct; 92(1):125-32. PubMed ID: 21713510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an oxygen-dependent inducible promoter, the Escherichia coli nar promoter, in gram-negative host strains.
    Lee KH; Cho MH; Chung T; Chang HN; Lim SH; Lee J
    Biotechnol Bioeng; 2003 May; 82(3):271-7. PubMed ID: 12599253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmable cells: interfacing natural and engineered gene networks.
    Kobayashi H; Kaern M; Araki M; Chung K; Gardner TS; Cantor CR; Collins JJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8414-9. PubMed ID: 15159530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetical and functional investigation of fliC genes encoding flagellar serotype H4 in wildtype strains of Escherichia coli and in a laboratory E. coli K-12 strain expressing flagellar antigen type H48.
    Beutin L; Strauch E; Zimmermann S; Kaulfuss S; Schaudinn C; Männel A; Gelderblom HR
    BMC Microbiol; 2005 Jan; 5():4. PubMed ID: 15663798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High isoprenoid flux Escherichia coli as a host for carotenoids production.
    Suh W
    Methods Mol Biol; 2012; 834():49-62. PubMed ID: 22144352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
    Sørensen HP; Mortensen KK
    J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of lycopene production by supplementing auxiliary carbon sources in metabolically engineered Escherichia coli.
    Kim YS; Lee JH; Kim NH; Yeom SJ; Kim SW; Oh DK
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):489-97. PubMed ID: 21246354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
    Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
    Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of SOS induction, recombinant gene expression, and multimerization of plasmid vectors in Escherichia coli.
    Lee J; Kim HC; Kim SW; Kim SW; Hong SI; Park YH
    Biotechnol Bioeng; 2002 Oct; 80(1):84-92. PubMed ID: 12209789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain.
    Chen C; Snedecor B; Nishihara JC; Joly JC; McFarland N; Andersen DC; Battersby JE; Champion KM
    Biotechnol Bioeng; 2004 Mar; 85(5):463-74. PubMed ID: 14760686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple functions of a feed-forward-loop gene circuit.
    Wall ME; Dunlop MJ; Hlavacek WS
    J Mol Biol; 2005 Jun; 349(3):501-14. PubMed ID: 15890368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed population control by cell-cell communication and regulated killing.
    You L; Cox RS; Weiss R; Arnold FH
    Nature; 2004 Apr; 428(6985):868-71. PubMed ID: 15064770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.